Literature DB >> 15342459

Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer.

Anne C Deitz1, Nathanial Rothman, Timothy R Rebbeck, Richard B Hayes, Wong-Ho Chow, Wei Zheng, David W Hein, Montserrat García-Closas.   

Abstract

Errors in genotype determination can lead to bias in the estimation of genotype effects and gene-environment interactions and increases in the sample size required for molecular epidemiologic studies. We evaluated the effect of genotype misclassification on odds ratio estimates and sample size requirements for a study of NAT2 acetylation status, smoking, and bladder cancer risk. Errors in the assignment of NAT2 acetylation status by a commonly used 3-single nucleotide polymorphism (SNP) genotyping assay, compared with an 11-SNP assay, were relatively small (sensitivity of 94% and specificity of 100%) and resulted in only slight biases of the interaction parameters. However, use of the 11-SNP assay resulted in a substantial decrease in sample size needs to detect a previously reported NAT2-smoking interaction for bladder cancer: 1,121 cases instead of 1,444 cases, assuming a 1:1 case-control ratio. This example illustrates how reducing genotype misclassification can result in substantial decreases in sample size requirements and possibly substantial decreases in the cost of studies to evaluate interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342459

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Acrylamine-induced autoimmune phenomena.

Authors:  Bruce Rothschild
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

2.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors:  Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype.

Authors:  David W Hein; Lori M Millner; Carmine S Leggett; Mark A Doll
Journal:  Carcinogenesis       Date:  2009-11-23       Impact factor: 4.944

Review 4.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.

Authors:  David W Hein; Mark A Doll
Journal:  Arch Toxicol       Date:  2017-05-18       Impact factor: 5.153

6.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

7.  N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.

Authors:  Olayinka A Kotila; Olufunmilayo I Fawole; Olufunmilayo I Olopade; Adejumoke I Ayede; Adeyinka G Falusi; Chinedum P Babalola
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

8.  Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.

Authors:  Todd M Gibson; Karin E Smedby; Christine F Skibola; David W Hein; Susan L Slager; Silvia de Sanjosé; Claire M Vajdic; Yawei Zhang; Brian C-H Chiu; Sophia S Wang; Henrik Hjalgrim; Alexandra Nieters; Paige M Bracci; Anne Kricker; Tongzhang Zheng; Carol Kolar; James R Cerhan; Hatef Darabi; Nikolaus Becker; Lucia Conde; Theodore R Holford; Dennis D Weisenburger; Anneclaire J De Roos; Katja Butterbach; Jacques Riby; Wendy Cozen; Yolanda Benavente; Casey Palmers; Elizabeth A Holly; Joshua N Sampson; Nathaniel Rothman; Bruce K Armstrong; Lindsay M Morton
Journal:  Cancer Causes Control       Date:  2012-11-18       Impact factor: 2.506

Review 9.  Exploring unknowns in cardiology.

Authors:  Ottavio Alfieri; Bongani M Mayosi; Seung-Jung Park; Nizal Sarrafzadegan; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2014-09-23       Impact factor: 32.419

10.  N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.

Authors:  Kathy B Baumgartner; Thomas J Schlierf; Dongyan Yang; Mark A Doll; David W Hein
Journal:  Toxicol Sci       Date:  2009-08-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.